We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Image: Canhelp‑UCa is a CE‑marked IVD molecular assay developed for the noninvasive detection and recurrence monitoring of urothelial carcinoma of the bladder and upper urinary tract (Photo courtesy of Canhelp Genomics)

New Distribution Agreement Expands Access to CE-Marked Precision Oncology Assays

Eurobio Scientific (Les Ulis, France) has signed a distribution agreement with Canhelp Genomics (Hangzhou, China) to broaden availability of the Canhelp‑UCa and Canhelp‑Origin assays. Read more
27 May 2026 | Industry
Image: Artera’s multi-modal AI platform analyzes digital pathology and clinical data to support personalized cancer management (photo courtesy of Artera)

Artera to Highlight AI-Based Cancer Risk Stratification at ASCO 2026

Artera’s (Los Altos, CA, USA) multimodal artificial intelligence (MMAI) platform will be featured in multiple presentations at the ASCO 2026 Annual Meeting, taking place May 29–June 2 in Chicago. Read more
27 May 2026 | Industry
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Read more
26 May 2026 | Pathology
Image: Using Diasorin’s Flex Software, laboratories can tailor target selection to seasonality, clinical presentation, current clinical guidelines, recent patient travel history, or immune status (Photo courtesy of Diasorin)

FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets

Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too narrow or too broad. Read more
26 May 2026 | Microbiology
Image: Primary central nervous system lymphoma (PCNSL) is a rare malignancy of the brain, spinal cord, and eyes that is often diagnosed late and associated with poor outcomes (Photo courtesy of Tdvorak / Wikimedia Commons / CC BY-SA 3.0)

Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma

Primary central nervous system lymphoma (PCNSL) is a rare malignancy of the brain, spinal cord, and eyes with delayed diagnosis and poor outcomes. Read more
26 May 2026 | Clinical Chem.
Image: Physicians currently use the Demicco score, which considers patient age, tumor size, and microscopic appearance, to estimate SFT aggressiveness, but uncertainty can remain about which patients need closer surveillance (image credit: Shutterstock)

Gene Fusion Patterns May Flag High Risk Solitary Fibrous Tumors

Solitary fibrous tumor (SFT) is a rare subtype of sarcoma, a cancer that develops in connective tissues such as fat, muscle, blood vessels, and fibrous tissue. Read more
26 May 2026 | Molecular Diagnostics
Image: BORCS5 regulates lysosomes, the cell’s waste-processing structures, with new findings linking mutations in the gene to severe neurological disorders (image credit: iStock)

Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders

Severe pediatric neurodevelopmental and neurodegenerative disorders can range from fatal prenatal syndromes to progressive disease in childhood, yet many cases remain unexplained. Read more
26 May 2026 | BioResearch
Image: At ASCO 2026, Natera’s oncology data program will feature 35 abstracts, including three oral presentations, focused on Signatera for pan-cancer MRD testing and the Treatment on MRD approach

Natera to Present Data on MRD-Guided Cancer Care at ASCO 2026

Natera, Inc. (Austin, TX, USA), a company focused on cell-free DNA testing and precision medicine, announced an oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29–June 2 in Chicago. Read more
26 May 2026 | Industry
Image: Fujifilm’s Synapse Pathology is a comprehensive pathology PACS that streamlines case management through proprietary advances in image digitization (photo courtesy of Fujifilm)

Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

FUJIFILM Healthcare Americas Corporation (Lexington, MA, USA) and mTuitive (Centerville, MA, USA) have formed a strategic partnership to integrate mTuitive’s structured pathology reporting platform with Fujifilm’s Synapse Pathology. Read more
26 May 2026 | Industry
Image: The new RNA origami method achieved 18-nucleotide resolution, enough to distinguish healthy from disease-associated repeat sections (image credit: Adobe Stock)

New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders

Repeat expansion disorders drive conditions such as myotonic dystrophy, Huntington’s disease, and amyotrophic lateral sclerosis (ALS), yet accurately sizing the mutated sequences remains difficult. Read more
23 May 2026 | Molecular Diagnostics
Evan P. Kransdorf et al., Population-Based Analysis of Rare Genetic Variants in Sudden Cardiac Arrest, JACC: Clinical Electrophysiology (2026). DOI: 10.1016/j.jacep.2026.03.016

Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals

Sudden cardiac arrest (SCA) is a frequently fatal electrical failure of the heart that is difficult to predict, as most victims have no prior warning signs. Read more
23 May 2026 | BioResearch
Image: New findings suggest that standard “normal” CA19-9 cutoffs may mask aggressive disease in nonproducers, while a dual-threshold model could reduce misinterpretation (image credit: Adobe Stock)

New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients

Pancreatic ductal adenocarcinoma (PDAC) is frequently diagnosed at an advanced stage and remains one of the most lethal solid tumors. Read more
22 May 2026 | Clinical Chem.
Image: Seegene’s Allplex MDRO Assay is designed to support detection of multidrug-resistant organisms (MDROs) (Photo courtesy of Seegene)

New AMR Assay Supports Rapid Infection Control Screening in Hospitals

As antimicrobial resistance spreads worldwide, healthcare-associated infections are placing a growing burden on hospitals, increasing the need for faster and broader diagnostic solutions. Read more
22 May 2026 | Microbiology
Image: Graphical Abstract (Crotts S.B., Barnes J.T., Antonetti R.M., et al. Cell Reports (2026). DOI:10.1016/j.celrep.2026.117347)

Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Read more
22 May 2026 | Immunology

Channels

Clinical Chemistry

view channel
International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
Image: The approach aims to complement symptom-based clinical assessments for psychosis with quantifiable molecular readouts (photo courtesy of Shutterstock)

Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction

Psychosis commonly emerges in adolescence or early adulthood and can severely disrupt social and occupational functioning. Hallucinations, delusions, and disorganized thinking often evolve gradually, hindering... Read more

Molecular Diagnostics

view channel
Microbial Saliva Test Could Help Triage Esophageal Cancer Risk
Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing
Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cance...
Image: The new Guardant360 Liquid CDx assay measures a 100‑fold wider genomic footprint than the previously approved Guardant360 CDx (Photo courtesy of Guardant Health)

FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

Timely, comprehensive tumor profiling helps clinicians make treatment selection decisions for patients with advanced cancer. Blood-based approaches can provide actionable insights from a simple draw and... Read more

Hematology

view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Image: The study’s findings may help identify iron deficiency earlier in children aged 5 to 14 years.(Photo courtesy of iStock)

Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children

Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more

Immunology

view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Biomarkers and Molecular Testing Advance Precision Allergy Care
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Image: The novel blood test could replace invasive biopsies for detecting acute cellular rejection after lung transplantation (image credit: 123RF)

Simple Blood Test Could Replace Biopsies for Lung Transplant Rejection Monitoring

Lung transplant recipients face some of the highest rates of acute cellular rejection, and routine surveillance often relies on repeated surgical biopsies. These procedures can cause complications such... Read more

Microbiology

view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospi...
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized...
Image: A member of the WHO Ebola ring vaccination team vaccinates a man in Bosolo village during a 2018 Ebola outbreak in Congo (Photo courtesy of WHO/Lindsay Mackenzie)

Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo

In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more

Pathology

view channel
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratificati...
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Image: Graphical Abstract (Eldad D. Shulman et al., AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology, Cell (2026). DOI: 10.1016/j.cell.2026.04.023)

Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images

Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more

Technology

view channel
AI Tool Automates Validation of Laboratory Software Configuration Changes
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Di...
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Image: QIA Agent is an AI-powered digital assistant designed to help users plan experiments, identify suitable products, access technical information, and manage ordering through a single interface (Photo courtesy of Qiagen)

AI-Enabled Assistant Unifies Molecular Workflow Planning and Support

Clinical laboratories and research groups face increasingly complex molecular workflows and expanding technical documentation spread across multiple systems. Fragmented digital tools can slow experiment... Read more

Industry

view channel
Partnership Brings Single-Cell Analysis into Clinical Oncology Workflows
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Partnership Aims to Bring Risk-Guided CKD Care to Health Systems
Image: The initiative will generate long‑read bulk RNA‑sequencing datasets to advance patient‑level prediction from tumor transcriptomes and support applications in biomarkers, clinical trial design, and diagnostics (Image courtesy of BlankBio)

Strategic Collaboration Advances RNA Foundation Models for Precision Oncology

Bulk RNA sequencing is increasingly used to study tumor biology, but standard analyses often reduce results to gene-level summaries that miss important transcript variants and mutation patterns.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE